Position in MRNA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$680,014,759
+$200,710,054 QoQ
Shares Held
9,710,335
+2.9% QoQ
Ownership
2.43%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#8
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. MRNA ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680,014,759 | 9,710,335 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $479,304,705 | 9,435,132 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $271,887,300 | 9,219,644 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $238,910,762 | 9,249,352 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $244,924,155 | 8,877,280 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $211,394,325 | 7,456,590 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $301,095,498 | 7,241,354 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $472,460,031 | 7,069,580 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $818,361,468 | 6,891,465 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $719,331,042 | 6,750,479 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $651,343,896 | 6,549,461 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $662,606,279 | 6,415,009 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $765,753,385 | 6,302,497 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $959,100,496 | 6,244,957 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,107,840,837 | 6,167,692 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $738,803,650 | 6,247,811 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $905,339,159 | 6,337,691 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,108,726,340 | 6,436,354 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,532,124,952 | 6,032,463 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,216,778,590 | 5,759,961 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $788,559,512 | 3,355,858 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $498,452,008 | 3,806,430 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $373,087,442 | 3,571,240 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $238,058,538 | 3,364,785 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $213,693,191 | 3,328,036 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $79,481,879 | 2,653,819 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||